Cholesterol-lowering drug to stabilize artery plaques after a heart event
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether a new injectable cholesterol-lowering drug (called a PCSK9 inhibitor) can help prevent further heart problems by making plaque in your arteries more stable and less likely to cause blocked vessels. It is for people who recently had a heart attack or unstable angina and already received a stent in the blocked artery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You recently had a heart attack or unstable angina and had a stent placed in the blocked artery
- You have a non-blocked artery with a mild to moderate narrowing (20–70% blockage) that has never been stented or bypassed before
- You are willing to take an experimental cholesterol-lowering medication and attend follow-up visits for at least a year
- You do not have severe heart failure, recent stroke, bleeding in the brain, or other unstable health conditions
- You are expected to live for more than one year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called a PCSK9 inhibitor (a type of drug that lowers bad cholesterol) can improve the buildup of plaque in heart arteries. It may be an option for people with coronary artery disease who have not been helped enough by statins alone.
This trial tests whether a single dose of a cholesterol-lowering drug called a PCSK9 inhibitor can improve heart outcomes after a stent procedure. If you recently had a stent and the imaging showed significant plaque, this may help reduce future risks.
This study tests whether adding a PCSK9 inhibitor (a newer cholesterol-lowering shot) to standard treatment can reduce heart risks in people who have certain high-risk plaque features seen on a CT scan of their heart arteries.
This study tests whether starting a cholesterol-lowering injection (a PCSK9 inhibitor) early after a heart attack can slow or shrink the buildup of plaque in other heart arteries that are not the one that was stented. If you have two other arteries with mild blockages, this treatment might help prevent future heart problems.
This trial tests whether a cholesterol-lowering drug (called a PCSK9 inhibitor) can help people who had a stroke and a procedure to clear a blocked vessel. It aims to see if the drug reduces the risk of another stroke or improves recovery.
This study tests a new class of cholesterol-lowering medicine (PCSK9 inhibitor) to see if it can make unstable plaques in the carotid artery more stable, reducing the risk of stroke. If you have carotid narrowing and high LDL despite statins, this might help prevent future problems.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.